Methylphenidate for ADHD in Children and Adolescents
The therapeutic effectiveness of methylphenidate (MPH) (0.3 mg/kg) in attention-deficit hyperactivity disorder (ADHD) was compared during childhood (ages 8 to 11 years) and adolescence (ages 12 to 14.5 years) in a retrospective follow-up study of 16 patients who had completed double-blind, placebo-c...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Книга |
| Опубліковано: |
Pediatric Neurology Briefs Publishers,
1998-03-01T00:00:00Z.
|
| Предмети: | |
| Онлайн доступ: | Connect to this object online. |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Інтернет
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Примірник 1 | Доступно |